Picard Medical to Feature 2,100-Implant SynCardia Heart and Next-Gen Platform March 14
Picard Medical’s SynCardia Total Artificial Heart, implanted in over 2,100 patients worldwide, will be featured on FOX Business News March 14 at 5 p.m. EST. The segment highlights development of a fully implantable platform to eliminate external drivers and enhance patient mobility, potentially increasing market adoption and investor interest.
1. Broadcast Feature Details
Picard Medical announced that its SynCardia Total Artificial Heart will be showcased on a BTV segment airing on FOX Business News on March 14 at 5 p.m. EST. The feature aims to introduce retail and institutional audiences to its artificial heart technology and upcoming platform advancements.
2. Clinical Track Record
The SynCardia Total Artificial Heart is the only FDA- and Health Canada–approved total artificial heart, with more than 2,100 implants performed across 27 countries. It provides full biventricular support by replacing both ventricles and all four heart valves in patients facing imminent death without mechanical circulatory support.
3. Next-Generation Platform Development
Picard Medical is advancing a fully implantable artificial heart platform designed to eliminate external pneumatic drivers. This next-generation system is intended to improve patient mobility and quality of life by removing tethered equipment and enabling longer-term, in-body support.
4. Investor and Market Implications
Increased media exposure on a national financial network could broaden investor awareness of Picard Medical’s leading position in mechanical circulatory support. Highlighting both the proven SynCardia device and emerging implantable technology may drive market adoption and influence future funding and partnership opportunities.